跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
楊 軒佳
副教授
,
醫學資訊研究所
https://orcid.org/0000-0001-9198-0697
電子郵件
lovejog
tmu.edu
tw
h-index
2323
引文
27
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2006
2024
每年研究成果
概覽
指紋
網路
專案
(8)
研究成果
(111)
資料集
(1)
類似的個人檔案
(8)
指紋
查看啟用 Hsuan-Chia Yang 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
4 Iodo 2,5 Dimethoxyamphetamine
16%
Acetylsalicylic Acid
9%
Adverse Event
10%
Antidepressant
8%
Atrial Fibrillation
16%
Breast Cancer
24%
Cancer Risk
64%
Case-Control Study
25%
Clinical Decision Support System
26%
Clinical Research
11%
Clinician
8%
Computerized Physician Order Entry
18%
COVID-19
33%
Disease
21%
Disease Association
8%
Drug Interaction
10%
Drug Therapy
35%
Drug Use
12%
Elderly Patient
9%
Electronic Health Record
36%
Electronic Patient Record
18%
Empathy
16%
Fatty Liver
11%
Health Care
13%
Laboratory Test
20%
Levothyroxine
16%
Logistic Regression Analysis
21%
Lung Cancer
17%
Malignant Neoplasm
52%
Medication Error
12%
Medicine
8%
Meta-Analysis
100%
Nonsteroid Antiinflammatory Agent
16%
Observational Study
47%
Odds Ratio
44%
Ophthalmology
9%
Patient Care
21%
Patient Safety
10%
Patient Satisfaction
9%
Physician
16%
Prevalence
10%
Proton-Pump Inhibitor
33%
Psoriasis
8%
Random Effects Model
9%
Sepsis
8%
Statin
10%
Stomach Cancer
9%
Systematic Review
35%
University Student
8%
Vaccination Coverage
8%
Pharmacology, Toxicology and Pharmaceutical Science
Acetylsalicylic Acid
17%
Adverse Event
18%
Aldosterone
8%
Angiotensin
16%
Angiotensin Receptor Antagonist
9%
Antidepressant
9%
Atrial Fibrillation
8%
Base
12%
Benzodiazepine
27%
Breast Cancer
42%
Cancer Registry
13%
Cardiovascular Disease
9%
Case-Control Study
28%
Chemotherapy
9%
Clinical Feature
9%
Clinical Research
19%
Cohort Study
25%
Colorectal Cancer
8%
Comorbidity
25%
Coronavirinae
16%
Dipeptidyl Carboxypeptidase Inhibitor
8%
Disease
66%
Drug Intolerance
8%
Drug-Drug Interaction
9%
Endometrium Cancer
8%
Female Genital Tract Cancer
8%
Hepatitis B Virus
8%
Hip Fracture
16%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
28%
Immune Checkpoint Inhibitor
8%
Infection
8%
Levothyroxine
16%
Liver Cancer
9%
Liver Cell Carcinoma
18%
Lung Cancer
20%
Malignant Neoplasm
81%
Medication Error
16%
Metformin
19%
Non-Steroidal Anti-Inflammatory Drug
16%
Observational Study
72%
Parkinson's Disease
16%
Prevalence
11%
Proton Pump Inhibitor
33%
Random Effects Model
15%
Randomized Controlled Trial
10%
Retrospective Study
9%
Statin (Protein)
45%
Stomach Cancer
10%
Traditional Chinese Medicine
18%
Uterine Cervix Cancer
8%
Nursing and Health Professions
4 Iodo 2,5 Dimethoxyamphetamine
8%
Artificial Intelligence
27%
Bibliometric Review
8%
Breast Cancer
10%
Case-Control Study
9%
Clinical Decision Support System
9%
Clinical Laboratory
8%
Confidence Interval
11%
Content Analysis
8%
Content Validity
8%
Diabetic Retinopathy
8%
Disease
28%
Drug Therapy
30%
Drug Use
8%
Dwell Time
8%
Electronic Health Record
21%
Electronic Medical Record
18%
Empathy
8%
Fatty Liver
16%
Filter
8%
Gout
8%
Health Care Personnel
9%
Health Literacy
16%
Hospital
8%
Laboratory Test
16%
Likert Scale
8%
Liver Cell Carcinoma
8%
Logistic Regression Analysis
13%
Lung Cancer
8%
Malignant Neoplasm
8%
Medication Compliance
8%
Medication Error
8%
Medication Therapy Management
8%
Meta Analysis
41%
National Health Insurance
12%
Non Melanoma Skin Cancer
8%
Nursing Staff
8%
Odds Ratio
11%
Patient Care
15%
Physician
10%
Pilot Study
25%
Psoriasis
13%
Psoriatic Arthritis
8%
Random Forest
8%
Receiver Operating Characteristic
22%
Sensitivity and Specificity
9%
Sepsis
8%
Statin (Protein)
8%
Systematic Review
9%
University Student
8%
